Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000015057
- Lead Sponsor
- Kitasato University School of Medicine,Endocrinology and Metabolism.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1. severe ketosis, diabetic coma, or before coma 2. before and not long after surgery,or patients with severe trauma 3. alcohol intake's excessive 4. patients who have a fever of 37.0 degrees or more 5. obvious infection 6. severe renal dysfunction or dialysis patients 7. patients with symptoms of urinary retention, difficulty urinating, anuria, or oliguria 8. severe liver dysfunction 9. patients with obvious active malignant tumor 10. women suspected of pregnancy or pregnant 11. patients with a history of use SGLT2 inhibitors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method